By Tony Fong

SAN FRANCISCO (GenomeWeb News) – Dutch molecular diagnostics firm Agendia plans on going public some time this year, a company official said.

At the JP Morgan Healthcare Conference in San Francisco this week, Bernhard Sixt, Agendia's president and CEO, told GenomeWeb Daily News that the company is planning an initial public offering this year, though a specific timeline and exchange has not yet been decided.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.